Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in AVTX — Avalo Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in AVTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$503,154
+$503,154 QoQ
Shares Held
27,227
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 126 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVTX Over Time

Shares Held

Position Value (USD)

Derivatives in AVTX

reported options exposure · as of Jun 30, 2026
CallValue
$4,470,312
CallShares
241,900
PutValue
$304,920
PutShares
16,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. AVTX ranks #159 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVTX

Export CSV
31 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,470,312 241,900
2026-06-30 $304,920 16,500
2026-06-30 $503,154 27,227
2026-03-31 $2,433,590 163,000
2026-03-31 $7,079,806 474,200
2025-12-31 $441,288 24,300
2025-12-31 $3,831,651 210,994
2025-12-31 $1,102,312 60,700
2025-09-30 $172,856 13,600
2025-09-30 $644,397 50,700
2025-09-30 $602,428 47,398
2023-09-30 $2,748 22,714
2022-12-31 $94,101 18,671
2022-03-31 $10,703 14,763
2022-03-31 $10,294 14,200
2021-12-31 $45,480 26,753
2021-12-31 $69,699 41,000
2021-12-31 $121,549 71,500
2021-09-30 $166,333 76,300
2021-09-30 $182,465 83,700
2021-09-30 $46,261 21,221
2021-06-30 CERC 125,895
2021-06-30 CERC 55,800
2021-06-30 CERC 83,200
2021-03-31 CERC 16,700
2021-03-31 CERC 36,200
2021-03-31 CERC 81,521
2020-12-31 CERC 25,811
2020-09-30 CERC 18,324
2020-06-30 CERC 14,994
2020-03-31 CERC 14,711